CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Clinical trial NCT06765876 · RECRUITING

Trial details

NCT number: NCT06765876
Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-Lymphoma Myelodysplastic Syndromes (MDS)Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Start date: 2024-10-23
Primary completion: 2028-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.